Swiss drug major Roche Holding AG (RHHBY) reported that its IFRS net income for fiscal year 2023 declined about 9% to 12.36 billion Swiss francs from 13.53 billion francs last year. But IFRS net income increased by 7% at constant exchange rates due to the increase in operating profit (IFRS) and lower income tax expenses.
Core earnings per share was 18.57 francs down from 20.30 francs in the prior year.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com